Severity
Moderate
FDA Drug recall · Reported May 25, 2022
CGMP Deviations: Failure to properly investigate failed microbial testing.
Plastikon Healthcare LLC recalled Acetaminophen Oral Solution, USP 650mg/ 20.3 mL cup, packaged in 10 cups per tray, 10 tra… - a moderate-severity action.
Acetaminophen Oral Solution, USP 650mg/ 20.3 mL cup, packaged in 10 cups per tray, 10 tra… was recalled by Plastikon Healthcare LLC in May 25, 2022. Reason: CGMP Deviations: Failure to properly investigate failed microbial testing.. Check the official notice for the remedy. Verify recall #D-0869-2022 with the FDA Drug before acting.
The recall
Plastikon Healthcare LLC issued this moderate-severity FDA Drug recall-CGMP Deviations: Failure to properly investigate failed microbial testing..
Sourced from official FDA Drug enforcement records. Verify recall #D-0869-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0869-2022) was formally reported on May 25, 2022, with the manufacturer initiating the action on March 24, 2022. It is classified under Moderate severity (Class II), with a current status of Completed. Plastikon Healthcare LLC is listed as the recalling firm, operating out of Lawrence, KS. Federal records list the affected scope as 121,800 Unit Dose cups, a scale large enough to require multi-state distribution tracking.
The documented reason for this recall is: CGMP Deviations: Failure to properly investigate failed microbial testing. Distribution data in the federal record shows the product reached: Distributed in Indiana for further distribution in the USA.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
121,800 Unit Dose cups
Related Recalls
6
5 from same agency
Acetaminophen Oral Solution, USP 650mg/ 20.3 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Distributed by Major Pharmaceuticals, Livonia, MI 48152, NDC: 0904-6820-76.
CGMP Deviations: Failure to properly investigate failed microbial testing.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Completed |
| Recall number | D-0869-2022 |
| Date reported | May 25, 2022 |
| Date initiated | March 24, 2022 |
| Recalling firm | Plastikon Healthcare LLC |
| Firm location | Lawrence, KS |
| Affected scope | 121,800 Unit Dose cups |
| Distribution | Distributed in Indiana for further distribution in the USA. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported May 25, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.